A Study of RSLV-132 in Females With Sjögren's Disease
NCT06440525
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
106
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Sjögren Syndrome
Interventions
DRUG:
RSLV-132
DRUG:
Placebo
Sponsor
Resolve Therapeutics